|
ZNF615 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17289955525735E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.38689973236706E-10 |
| Normal-vs-Stage2 |
2.5233000022773E-08 |
| Normal-vs-Stage3 |
4.27210000042422E-07 |
| Normal-vs-Stage4 |
1.961410E-03 |
| Stage1-vs-Stage2 |
5.659200E-01 |
| Stage1-vs-Stage3 |
8.569400E-01 |
| Stage1-vs-Stage4 |
3.494200E-01 |
| Stage2-vs-Stage3 |
8.053600E-01 |
| Stage2-vs-Stage4 |
5.121800E-01 |
| Stage3-vs-Stage4 |
3.787400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15569784245417E-11 |
| Normal-vs-AfricanAmerican |
2.370900E-04 |
| Normal-vs-Asian |
7.298600E-03 |
| Caucasian-vs-AfricanAmerican |
1.648160E-01 |
| Caucasian-vs-Asian |
4.638400E-01 |
| AfricanAmerican-vs-Asian |
9.870400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.85853587864449E-12 |
| Normal-vs-Female |
1.577710E-04 |
| Male-vs-Female |
6.849100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.218670E-03 |
| Normal-vs-Extreme_Weight |
1.65012448150037E-12 |
| Normal-vs-Obese |
4.33640000019331E-07 |
| Normal-vs-Extreme_Obese |
6.404200E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.292300E-02 |
| Normal_Weight-vs-Obese |
9.386000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.763800E-01 |
| Extreme_Weight-vs-Obese |
3.196300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.205000E-01 |
| Obese-vs-Extreme_Obese |
8.978200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.51229999999503E-05 |
| Normal-vs-Age(41-60Yrs) |
2.77799999670592E-08 |
| Normal-vs-Age(61-80Yrs) |
3.35139693774522E-11 |
| Normal-vs-Age(81-100Yrs) |
9.92509999964142E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.452600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.223800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.910600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.053600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.817800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.664600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.96219707149226E-11 |
| Normal-VS-Type2 PRCC |
2.17810214309111E-11 |
| Normal-VS-KIRP CIMP |
2.158800E-04 |
| Normal-VS-Unclassified PRCC |
3.154300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.789900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.922400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.741400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.884400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.482400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.741400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.65134614052931E-13 |
| Normal-vs-N1 |
7.197300E-04 |
| Normal-vs-N2 |
2.19940000001362E-06 |
| N0-vs-N1 |
2.044000E-01 |
| N0-vs-N2 |
1.159160E-01 |
| N1-vs-N2 |
1.384160E-01 |
|
|
